SPEAKERS

Dr John Altin, Assistant Professor, Pathogen and Microbiome Division, Translational Research Genomics Research Institute

Dr David E. Anderson, CSO, VBI Vaccines

Jon Armstrong, Chief Scientific Officer, Cofactor Genomics

Prof Laure Aurelian, Professor, University of Maryland School of Medicine

Dr Jessica Baker Flechtner, Chief Scientific Officer, Genocea Biosciences, Inc.

Stuart Barich, Managing Director Healthcare Investment Banking, Raymond James

Dr Sean Bennett, Director of Senior Clinical Development and Medical Affairs, PaxVax Inc

Dr Kara Bortone, Head JLABS San Diego, Johnson & Johnson Innovation, California-JJDC, Inc

Dr Dennis Burton, Co-chair Department of Immunology and Microbiology, The Scripps Research Institute

Dr Darrick Carter, Vice President - Adjuvant Technology, I.D.R.I.

Dr Edward Cha, Associate Medical Director, Genentech

Dr Ezra Cohen, Associate Director of Moores Cancer Center, U.C. San Diego Moores Cancer Center

Dr James Crowe, Director of Vanderbilt Vaccine Center, Vanderbilt

Dr Rajeev Dadoo, Partner, S.R. One

Dr Roger Dansey, Senior Vice President and Therapeutic Area Head, Oncology Late-stage Development, Laboratories, Merck & Co.

Dr Adil Daud, Professor of Hematology, Oncology and Director, U.C.S.F. Helen Diller Family Comprehensive Cancer Center

Dr Jason DeVoss, Senior Scientist,, Amgen

Iana Dimkova, Director Healthcare Investing, G.E. Ventures

Mr Erin E.Jones, Senior Vice President & Global Head Of Regulatory Affairs & Quality Assurance/Quality, Gritstone Oncology

Dr Michael Eisenbraun, Director of Immunology, Cancer Vaccines & Immunotherapeutics, Pfizer

Dr Robert Florkiewicz, Head of Molecular Biology and Virology, TapImmune Inc

Simon Gill, Managing Director, Needham and Co Llc

Dr Fabian Gusovsky, Executive Director at C.S.O. Group P.C.H.Q., Eisai Pharmaceuticals Inc

Dr Tarek Hamouda, Director of Senior Medical and Vaccines, Pfenex Inc

Drew Hannaman, Vice President of Research and Development, Ichor Medical Systems

Dr Audray Harris, Investigator, National Institutes of Health

Dr Colin Havenar-Daughton, Scientific Associate, La Jolla Institute for Allergy and Immunology

Tim Hirst, , Angel Investor

Dr Robert Hollingsworth, Vice-President & CSO, Cancer Vaccines & Immunotherapeutics, Pfizer

Dr Peter Hotez, Dean, National School of Tropical Medicine, Director, Texas Children’s Hospital Center, Baylor College of Medicine

Dr Karin Jooss, Chief Scientific Officer, Gritstone Oncology

Dr Anusha Kalbasi, Assistant Professor, Chief, Sarcoma Radiation Oncology Service, U.C.L.A. Jonsson Comprehensive Cancer Center

Dr Michael Kalos, Chief Scientific Officer, Cancer Immunobiology, Eli Lilly and Co

Dr Kurt Kamrud, Senior Director, Viral Systems, Synthetic Genomics

Dr Maria Karasarides, Executive Director, ImmunoOncology, Regeneron Pharmaceuticals

Dr Alan Korman, Vice President of Immuno Oncology, Bristol Myers Squibb

Dr William Kuziel, Director of External Scientific Affairs, Daiichi Sankyo Group

Sooin Kwon, Partner, Life Sciences, M.T.S. Health Partners

Dr Theresa LaVallee, Head of Translational Medicine, Parker Institute for Cancer Immunotherapy

Dr John Lee, Senior Vice President, Adult Medical Affairs. Co-Director, Chan Soon-Shiong Institutes for Medicine, NantKwest

Dr Ke Liu, Chief, Oncology Branch, Acting Associate Director for Oncology Cell and Gene Therapy, Oncology Center of Excellence, Food and Drug Administration

Dr Tao Long, Assistant Professor, Sanford Burnham Prebys Medical Discovery Institute

Dr Wouter Meuleman, Director, Venture Investments, Illumina Ventures

Dr Timothy Mills, Managing Director, Sanderling Ventures

Dr Kayvon Modjarrad, Chief, Emerging Infectious Diseases, Walter Reed Army Institute of Research

Mr Keegan Moore, Director, Regional Sales, World Courier

Terry Moore, Founder and Managing Partner, Moore Venture Partners, LP

Stephen Nagler, Executive Director, MedPro Investors LLC

Dr Franco Pissani, Vice President, Business Development & Scientific Advisor, Mabtech

Dr Hari Pujar, Vice President Technical Development and Manufacturing, Moderna Therapeutics

Prof Bali Pulendran, Department of Pathology, Microbiology&Immunology, Stanford University School of Medicine

Dr Cindy Ru, EVP & CSO, CRC Oncology Corp.

Dr Manish Sadarangani, Assistant Professor, Pediatric Infectious Diseases, University of British Columbia Director, Vaccine Evaluation Center, BC Children?s Hospital Research Institute

Dr Jerald Sadoff, Senior Advisor Vaccine Development, Janssen Infectious Diseases and Vaccines

Dr Michael Salgaller, Supervisory Invention Development and Marketing Manager – IDM Unit, National Cancer Institute, National Institutes of Health

Dr Richard Scheuermann, Director, J Craig Venter Institute

Dr Alessandro Sette, Professor, Head and Member, La Jolla Infectious Disease Institute

Ruchita Sinha, Senior Director of Investments, Sanofi Genzyme BioVentures

Dr Robert Sinkovits, Director Scientific Applications Group, Gordon Applications Lead, San Diego Supercomputer Center

Mr Paolo Sison, Director, Innovative Finance, Gavi, The Vaccine Alliance

Dr Thomas Stricker, Assistant Professor, Director, CALDx-Center for Advanced Lab Diagnostics, Representative ACCR GENIE Working Group, Vanderbilt University Medical Center

Dr Joann Suzich, Vice President of Infectious Disease and Vaccines Research, MedImmune Ventures Inc.

Dr Sybil Tasker, Chief Medical Officer, Altimmune

Dr Steve Thorne, Chief Scientific Officer, Western Oncolytics

Dr Steven Townson, Principal Scientist, Clinical Research Oncology Early Development, Merck & Co Inc

Dr Sean Tucker, CSO and VP Research, Vaxart

Dr Andrea Van Elsas, Chief Scientific Officer, Aduro BioTech Inc

Dr Joseph Vinetz, Professor of Medicine, Division of Infectious Diseases, University of California San Diego

Get involved

To exhibit, sponsor or speak at the event contact
Oliver Breed on +44 (0)20 7092 1156
or oliver.breed@terrapinn.com